Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
Summary generated by The Flow from the publisher's feed. The full article lives at DeepMind Blog.
Geneticist Catherine Brownstein demonstrates how OpenAI o1 can speed up the process of diagnosing rare medical challenges.
Researchers used an OpenAI reasoning model to help diagnose rare diseases, identifying 18 new diagnoses in previously unsolved cases.
Introducing a new, unifying DNA sequence model that advances regulatory variant-effect prediction and promises to shed new light on genome function — now available via API.
OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
We’re developing a blueprint for evaluating the risk that a large language model (LLM) could aid someone in creating a biological threat. In an evaluation involving both biology experts and students, we found that GPT-4 provides at most a mild uplift in biological threat creation accuracy.
Stanford geneticist uses Co-Scientist to help find new treatments for chronic liver disease and liver fibrosis.
